What Is NAD+, Ketamine Wellness Center's New Therapy?
Delic Holdings Corp.’s (OTCQB: DELCF) subsidiary Ketamine Wellness Centers will start offering a new therapy in some of its locations: NAD+ infusion therapy.
Starting on May 9, the clinics in Jacksonville, Houston, Salt Lake City, Dallas, Las Vegas and Tucson will introduce the new therapy to their offerings.
NAD+ is a fundamental coenzyme found in every cell of the body thought to have multiple beneficial effects, especially in maintaining cell health. The problem is that with age NAD+ levels naturally decrease.
Currently, there are numerous brands that sell the molecule as a supplement, such as Tru Niagen, Bulletproof, Theagehack and UltraNMN, but the offering for intravenous or intramuscular administration is much lower.
"The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being,” commented Kevin Nicholson, CEO of Delic and KWC.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Delic Holdings Corp.Biotech Cannabis News Penny Stocks Psychedelics Markets General Best of Benzinga